Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine
Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Rivia, a Zurich-based startup specialising in AI-driven analytics and clinical trial data infrastructure for BioTechs, today announced a €13 million ($15 million) Series A to accelerate team growth, scale agentic product development, and expand its international presence, especially in the US. The round was led by Earlybird, with participation from Defiant and existing investors Speedinvest, […] The post Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine appeared first on EU-Startups.